DK0631776T3 - Anvendelse af beta-naphthoquinonderivater til at accelerere væksten af endothelceller og hæmme NO-syntetaser - Google Patents

Anvendelse af beta-naphthoquinonderivater til at accelerere væksten af endothelceller og hæmme NO-syntetaser

Info

Publication number
DK0631776T3
DK0631776T3 DK94401460T DK94401460T DK0631776T3 DK 0631776 T3 DK0631776 T3 DK 0631776T3 DK 94401460 T DK94401460 T DK 94401460T DK 94401460 T DK94401460 T DK 94401460T DK 0631776 T3 DK0631776 T3 DK 0631776T3
Authority
DK
Denmark
Prior art keywords
beta
endothelial cells
synthetases
accelerate
inhibit
Prior art date
Application number
DK94401460T
Other languages
English (en)
Inventor
Christian Bloy
Jean-Pierre Cazenave
Bernard Hercelin
Bernard Teisseire
Original Assignee
Hoechst Marion Roussel Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel Inc filed Critical Hoechst Marion Roussel Inc
Application granted granted Critical
Publication of DK0631776T3 publication Critical patent/DK0631776T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/17Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A61K31/175Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine having the group, >N—C(O)—N=N— or, e.g. carbonohydrazides, carbazones, semicarbazides, semicarbazones; Thioanalogues thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/14Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK94401460T 1993-07-02 1994-06-28 Anvendelse af beta-naphthoquinonderivater til at accelerere væksten af endothelceller og hæmme NO-syntetaser DK0631776T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9308111A FR2707494B1 (fr) 1993-07-02 1993-07-02 Nouvelle utilisation de dérivés de la béta-naphtoquinone ainsi que de leurs sels.

Publications (1)

Publication Number Publication Date
DK0631776T3 true DK0631776T3 (da) 2001-03-05

Family

ID=9448827

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94401460T DK0631776T3 (da) 1993-07-02 1994-06-28 Anvendelse af beta-naphthoquinonderivater til at accelerere væksten af endothelceller og hæmme NO-syntetaser

Country Status (13)

Country Link
US (1) US5478821A (da)
EP (1) EP0631776B1 (da)
JP (1) JP3993647B2 (da)
AT (1) ATE197668T1 (da)
CA (1) CA2127214C (da)
DE (1) DE69426316T2 (da)
DK (1) DK0631776T3 (da)
ES (1) ES2154285T3 (da)
FR (1) FR2707494B1 (da)
GR (1) GR3035059T3 (da)
HU (1) HU214716B (da)
PT (1) PT631776E (da)
RU (1) RU2131246C1 (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0758890T3 (da) 1994-05-11 2005-04-18 Jes Olesen Anvendelse af NO indfangere, inhibitorer eller antagonister ved behandling af migræne
FR2722507B1 (fr) * 1994-07-12 1996-08-14 Rhone Poulenc Rorer Sa Adenovirus comportant un gene codant pour une no synthase
WO1997005871A1 (en) * 1995-08-09 1997-02-20 Ontogen Corporation Nitric oxide synthase (nos) inhibitors
JP2001512471A (ja) * 1997-02-21 2001-08-21 バイヤースドルフ・アクチエンゲゼルシヤフト しゅさの処置のための調製物
IT1312537B1 (it) * 1999-04-16 2002-04-22 Euphar Group Srl Derivati del (-)- verbenone.
JP4989830B2 (ja) * 1999-07-21 2012-08-01 サーントゥル ナシオナル ドゥ ラ ルシェルシュ シャーンティフィク 脳によるグルタミン酸塩の放出に対して抑制効果を示す薬剤を製造するためのベータ−ナフトキノン誘導体の使用
WO2018156917A1 (en) * 2017-02-23 2018-08-30 The Cleveland Clinic Foundation Anti-aging compounds

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2395638A (en) * 1941-03-07 1946-02-26 Research Corp Hydroxylation of aromatic hydrocarbons
FR924M (da) * 1959-09-26 1961-11-13
US3758520A (en) * 1971-07-23 1973-09-11 C Beaudet Process for the preparation of beta-naphthoquinone semicarbazone
JPH037806A (ja) * 1989-06-05 1991-01-16 Masamoto Kaneko 廃棄物の処理方法及び装置

Also Published As

Publication number Publication date
PT631776E (pt) 2001-05-31
DE69426316T2 (de) 2001-05-03
FR2707494A1 (fr) 1995-01-20
DE69426316D1 (de) 2000-12-28
RU2131246C1 (ru) 1999-06-10
US5478821A (en) 1995-12-26
RU94022756A (ru) 1996-09-10
HUT70507A (en) 1995-10-30
EP0631776B1 (fr) 2000-11-22
HU9401977D0 (en) 1994-09-28
ATE197668T1 (de) 2000-12-15
JP3993647B2 (ja) 2007-10-17
ES2154285T3 (es) 2001-04-01
GR3035059T3 (en) 2001-03-30
JPH07145129A (ja) 1995-06-06
HU214716B (hu) 1998-05-28
CA2127214A1 (fr) 1995-01-03
EP0631776A1 (fr) 1995-01-04
CA2127214C (fr) 2004-10-26
FR2707494B1 (fr) 1995-08-25

Similar Documents

Publication Publication Date Title
DK620489A (da) Enzymhaemmende urinstofderivater af dipeptider, deres fremstilling og anvendelse som laegemidler
AU529426B2 (en) 4-amino-2-ureido-pyrimidine-5-carboxylic acid anilides and their use in treating lipometabolism disturbances and adiposity
MD1507F2 (en) Inhibitors, pharmaceutical composition on base thereof and process for HIV protease inhibition
DK0615458T3 (da) Fremgangsmåde til reduktion af infektioner relateret til medicinske anordninger
FI893262A0 (fi) Nya disfosfonsyraderivat, foerfarande foer deras framstaellning och laekemedel innehaollande dessa foereningar.
DK97890D0 (da) Fremgangsmaade til fremstilling af mevalolactonanaloge
AU3242689A (en) Process for preparing derivatives of baccatine iii and of 10-deacetyl baccatine iii
DK0590271T3 (da) 17beta-aryl- og 17beta-heterocyclyl-5alfa, 14beta-androstan-, androsten- og -androstadienderivater med aktivitet på det kardiovaskulære system, fremgangsmåde til fremstilling af disse og farmaceutiske præparater indeholdende disse
GR3017128T3 (en) Treatment of hiv infections and compounds useful therein.
ES2102475T3 (es) Nuevas alquil-amidas heterociclicas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.
IL73152A0 (en) Cyclohexenol derivatives and their use as herbicides
DK0631776T3 (da) Anvendelse af beta-naphthoquinonderivater til at accelerere væksten af endothelceller og hæmme NO-syntetaser
FI102239B1 (fi) Mikrobiologisen kasvun estämiseen käyttökelpoinen 2-(tiosyanometyylitio)bentsotiatsolia ja 2,4,6-tribromifenolia sisältävä koostumus ja menetelmä mikro-organismien kasvun estämiseksi sen avulla
DK72289D0 (da) Cephemcarboxylsyreestere, deres fremstilling og anvendelse
FI891581A0 (fi) Peptidderivat.
AU2002213579A1 (en) Medicaments for treating dementia
GB2324528B (en) Cytostatic hydroxamic acid derivatives
SE8303136L (sv) Optiskt aktiva derivat av n-arylerat oxazolidinon-2, specifika och reversibla inhibitorer av monoaminoxydas av typ b, och deras framstellningssett
AU2566101A (en) Compounds and methods for the treatment of pain
IL87561A (en) 4-aminoethyl-2,3-dihydro- 2-benzimidazol and thione derivatives and pharmaceutical compositions containing the same
FI901237A0 (fi) Ws7622a-, b-, c- och d-substanser, deras derivat, foerfarande foer deras framstaellning och deras anvaendning.
DK284588D0 (da) Beta-lactam-forbindelser, deres fremstilling og anvendelse som laegemidler.
DE3772909D1 (de) 3-methylphthalimide.
DK0631777T3 (da) Anvendelse af beta-naphtoquinonderivater til hæmning af blodpladesammenklumpning
DK31383A (da) Anvendelse som plantevaekstfaktorer af 0-phenylhydroxylamin og af visse derivater deraf